ADRM Insider Trading Activity and SEC Form 4 Filings
ADRM insider trading summary
No open-market insider purchases or sales of Aduromed Industries, Inc. (ADRM) have been reported on SEC Form 4 in the past 12 months.
Latest ADRM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 28, 2008 | Damien R Tanaka | Chief Development Officer | Sell | $28K (200,000 @ $0.14) |
| Aug 7, 2008 | Kevin T Dunphy | Chief Financial Officer | Buy | $25K (2,000,000 @ $0.01) |
| Aug 5, 2008 | Jack Silver | 10% Owner | Sell | $16K (94,000 @ $0.17) |
| Aug 4, 2008 | Pequot Capital Management Inc | Insider | Buy | $126047.58B (112,743,812 @ $1118000.00) |
| Aug 4, 2008 | Jack Silver | 10% Owner | Buy | $602K (24,080,000 @ $0.03) |
| Aug 4, 2008 | Jack Silver | 10% Owner | Sell | $23K (140,000 @ $0.17) |
| Jul 11, 2008 | Jack Silver | 10% Owner | Buy | $98K (3,920,000 @ $0.03) |
| Jul 11, 2008 | Pequot Capital Management Inc | Insider | Buy | $3340.36B (18,353,644 @ $182000.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.